Top brokerage firm Prabhudas Lilladher has given an 'accumulate' rating to the stock of Aurobindo Pharma. "We cut our FY23-25E EPS est. by 10-17% to factor in lower margins and US sales. Aurobindo Pharma's (ARBP) performance was weak in H1FY23, given cost
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/Q6h31I4
via IFTTT
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/Q6h31I4
via IFTTT